{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-035433","form_type":"8-K","ticker":"BKYI","cik":"0001019034","company_name":"BIO KEY INTERNATIONAL INC","filed_at":"2024-11-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.394195+00:00","generated_at":"2026-05-29T23:32:28.784444+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"BIO-key Q3 revenue up 18% to $2.1M; net loss narrows to $0.7M from $1.8M","bullets":["Revenue $2.1M vs $1.8M; license revenue rose 52% to $1.4M on expanded customer deployments.","Gross margin improved to 78.3% from 18.7%; net loss per share $0.39 vs $3.22 YoY.","Cash position strengthened to $1.8M at Sep 30 from $0.5M at Dec 31, aided by $1.9M warrant inducement.","Recent orders: $910k from financial services customer, $500k from defense ministry; 10,000 users added by British Columbia.","Full-year 2024 revenue expected to meet or exceed $7.75M achieved in 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-035433","json":"https://secwatch.observer/filing/0001437749-24-035433.json","markdown":"https://secwatch.observer/filing/0001437749-24-035433.md","text":"https://secwatch.observer/filing/0001437749-24-035433.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1019034/000143774924035433/0001437749-24-035433-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1019034/000143774924035433/bkyi20241114_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T23:32:28.784444+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}